EFFECTS OF ANTI-PARKINSON DRUGS ON CORTICAL NEURONS

被引:11
|
作者
CLARKE, G [1 ]
DAVIES, J [1 ]
机构
[1] UNIV LONDON,SCH PHARM,DEPT PHARMACOL,LONDON WCIN 1AX,ENGLAND
关键词
D O I
10.1111/j.1476-5381.1973.tb08178.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:465 / 475
页数:11
相关论文
共 50 条
  • [31] Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: A model for anti-Parkinson testing
    Chalorak, Pawanrat
    Jattujan, Prapaporn
    Nobsathian, Saksit
    Poomtong, Tanate
    Sobhon, Prasert
    Meemon, Krai
    NUTRITIONAL NEUROSCIENCE, 2018, 21 (06) : 427 - 438
  • [32] UTILIZATION OF ANTI-PARKINSON DRUGS IN NORWAY, SWEDEN, DENMARK AND FINLAND 1975-1979
    AQUILONIUS, SM
    GRANAT, M
    HARTVIG, P
    ACTA NEUROLOGICA SCANDINAVICA, 1981, 64 (01): : 47 - 53
  • [34] Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
    Bar Am, O
    Amit, T
    Youdim, MBH
    NEUROSCIENCE LETTERS, 2004, 355 (03) : 169 - 172
  • [35] Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010
    Nakaoka, Sachiko
    Ishizaki, Tatsuro
    Urushihara, Hisashi
    Satoh, Toshihiko
    Ikeda, Shunya
    Yamamoto, Mitsutoshi
    Nakayama, Takeo
    PLOS ONE, 2014, 9 (06):
  • [36] Binding of Anti-Parkinson's Disease Drugs to Human Serum Albumin is Allosterically Modulated
    Fanali, Gabriella
    Rampoldi, Viviana
    di Masi, Alessandra
    Bolli, Alessandro
    Lopiano, Leonardo
    Ascenzi, Paolo
    Fasano, Mauro
    IUBMB LIFE, 2010, 62 (05) : 371 - 376
  • [37] CENTRAL NERVOUS-SYSTEM AND AUTONOMIC NERVOUS-SYSTEM EFFECTS OF AMANTADINE AND OF SOME STANDARD ANTI-PARKINSON DRUGS
    BIANCHI, C
    TOMASI, L
    PHARMACOLOGY, 1973, 10 (04) : 226 - 237
  • [38] Optimization of Parkinson Disease Treatment Combining Anti-Parkinson Drugs and Deep Brain Stimulation Using Patient Diaries
    Schneider, Jakub
    Novak, Daniel
    Jech, Robert
    2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2015, : 3444 - 3447
  • [39] An anti-parkinson botanical with symptomatic and neuroprotective effect
    Manyan, BV
    MOVEMENT DISORDERS, 2006, 21 : S113 - S113
  • [40] Anti-Parkinson's disease drug is withdrawn
    不详
    CHEMISTRY IN BRITAIN, 1999, 35 (02) : 10 - 10